ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
CureVac Appoints Chief Development Officer contractpharma
June 03, 2021?CureVac N.V., a global clinical-stage biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA), has appointed Klaus Edvardsen, MD, PhD, as chief development officer. -
Avacta Appoints Chief Development Officer contractpharma
August 12, 2020Neil Bell brings 30 years’ experience in the drug development industry.
Pharma Sources Insight January 2025
